Nisa Investment Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,797
Closed -$964K 2987
2025
Q2
$964K Sell
9,797
-5,363
-35% -$507K ﹤0.01% 819
2025
Q1
$1.4M Buy
15,160
+10
+0.1% +$922 0.01% 736
2024
Q4
$1.38M Buy
15,150
+180
+1% +$16.5K 0.01% 791
2024
Q3
$1.44M Sell
14,970
-300
-2% -$29.3K 0.01% 757
2024
Q2
$1.4M Hold
15,270
0.01% 794
2024
Q1
$1.41M Hold
15,270
0.01% 771
2023
Q4
$1.45M Hold
15,270
0.01% 745
2023
Q3
$1.43M Hold
15,270
0.01% 765
2023
Q2
$1.4M Buy
15,270
+300
+2% +$24.6K 0.01% 788
2023
Q1
$1.1M Buy
14,970
+3
+0% +$260 0.01% 835
2022
Q4
$1.25M Buy
14,967
+3
+0% +$270 0.01% 850
2022
Q3
$1.45M Sell
14,964
-56
-0.4% -$6.68K 0.01% 716
2022
Q2
$1.58M Hold
15,020
0.01% 696
2022
Q1
$2.59M Buy
+15,020
New +$2.24M 0.02% 599
2021
Q4
Sell
-15,230
Closed -$2.27K 2181
2021
Q3
$2.27K Sell
15,230
-1,744
-10% -$363K 0.01% 673
2021
Q2
$4.16K Hold
16,974
0.03% 503
2021
Q1
$4.5K Hold
16,974
0.03% 478
2020
Q4
$4.98M Buy
16,974
+1,019
+6% +$261K 0.03% 448
2020
Q3
$3.77M Buy
15,955
+715
+5% +$163K 0.03% 436
2020
Q2
$3.03M Sell
15,240
-180
-1% -$33.6K 0.03% 474
2020
Q1
$2.83M Buy
15,420
+300
+2% +$53.4K 0.03% 433
2019
Q4
$2.52M Hold
15,120
0.02% 565
2019
Q3
$1.98M Buy
15,120
+70
+0.5% +$9.11K 0.02% 650
2019
Q2
$1.83M Hold
15,050
0.02% 666
2019
Q1
$1.85M Sell
15,050
-50
-0.3% -$6.28K 0.02% 643
2018
Q4
$1.77M Sell
15,100
-16,987
-53% -$2M 0.02% 601
2018
Q3
$4.01M Buy
32,087
+16,987
+112% +$1.88M 0.04% 427
2018
Q2
$1.29M Hold
15,100
0.01% 743
2018
Q1
$911K Sell
15,100
-50
-0.3% -$2.85K 0.01% 852
2017
Q4
$799K Hold
15,150
0.01% 904
2017
Q3
$848K Hold
15,150
0.01% 873
2017
Q2
$952K Sell
15,150
-1,800
-11% -$105K 0.01% 826
2017
Q1
$866K Sell
16,950
-550
-3% -$26.2K 0.01% 856
2016
Q4
$746K Hold
17,500
0.01% 910
2016
Q3
$830K Hold
17,500
0.01% 851
2016
Q2
$883K Hold
17,500
0.01% 810
2016
Q1
$846K Buy
+17,500
New +$675K 0.01% 813

Other funds holding AMED

Nisa Investment Advisors's AMED Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 9,797 shares — an estimated $964K sold.

Nisa Investment Advisors first reported a position in AMED in Q1 2016 and held it in 37 quarters. The position peaked at $4.98M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 9,797 Amedisys shares in Q3 2025, an estimated $964K.
  • Nisa Investment Advisors first reported a position in Amedisys in Q1 2016 and held it in 37 quarters.
  • Nisa Investment Advisors's Amedisys position peaked at $4.98M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.